U.S. RESEARCH ROUNDUP-Century Therapeutics, Mastec, Quanta Services
27/12/2022 13:57
Dec 27 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Century Therapeutics, Mastec and Quanta
Services, on Tuesday.
HIGHLIGHTS
* Century Therapeutics Inc IPSC.O : Chardan Capital Markets initiates with buy rating
* Mastec Inc MTZ.N : Cowen and Company cuts target price to $120 from $125
* Quanta Services Inc PWR.N : Cowen and Company raises target price to $165 from $155
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.
* Century Therapeutics Inc IPSC.O : Chardan Capital Markets initiates with buy rating
* Century Therapeutics Inc IPSC.O : Chardan Capital Markets initiates with $19 target price
* Cto Realty Growth Inc CTO.N : BTIG cuts target price to $21 from $24
* Mastec Inc MTZ.N : Cowen and Company cuts target price to $120 from $125
* Quanta Services Inc PWR.N : Cowen and Company raises target price to $165 from $155
* Quipt Home Medical Corp QIPT.O : Benchmark raises target price to $9 from $8
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))